Long-term mortality and causes of death in isolated GHD, ISS and SGA patients treated with Recombinant Growth Hormone during childhood in Belgium, The Netherlands and Sweden: Preliminary report of 3 countries participating in the EU SAGhE Studdy

L Savendahl; M Maes; K Albertsson-Wikland; B Borgstrom; JC Carel; S Henrard; N Speybroeck; M Thomas; G Zandwijken; Anita Hokken - Koelega

doi:10.1210/jc.2011-2882

Long-term mortality and causes of death in isolated GHD, ISS and SGA patients treated with Recombinant Growth Hormone during childhood in Belgium, The Netherlands and Sweden: Preliminary report of 3 countries participating in the EU SAGhE Studdy

L Savendahl, M Maes, K Albertsson-Wikland, B Borgstrom, JC Carel, S Henrard, N Speybroeck, M Thomas, G Zandwijken, Anita Hokken - Koelega

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

153 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	E213-E217
Journal	Journal of Clinical Endocrinology and Metabolism
Volume	97
Issue number	2
DOIs	https://doi.org/10.1210/jc.2011-2882
Publication status	Published - 2012

Research programs

EMC MM-01-54-01

Access to Document

10.1210/jc.2011-2882

http://hdl.handle.net/1765/60877

Cite this

Savendahl, L., Maes, M., Albertsson-Wikland, K., Borgstrom, B., Carel, JC., Henrard, S., Speybroeck, N., Thomas, M., Zandwijken, G., & Hokken - Koelega, A. (2012). Long-term mortality and causes of death in isolated GHD, ISS and SGA patients treated with Recombinant Growth Hormone during childhood in Belgium, The Netherlands and Sweden: Preliminary report of 3 countries participating in the EU SAGhE Studdy. Journal of Clinical Endocrinology and Metabolism, 97(2), E213-E217. https://doi.org/10.1210/jc.2011-2882

Savendahl, L ; Maes, M ; Albertsson-Wikland, K et al. / Long-term mortality and causes of death in isolated GHD, ISS and SGA patients treated with Recombinant Growth Hormone during childhood in Belgium, The Netherlands and Sweden: Preliminary report of 3 countries participating in the EU SAGhE Studdy. In: Journal of Clinical Endocrinology and Metabolism. 2012 ; Vol. 97, No. 2. pp. E213-E217.

@article{cb8d58dc4fe64380a26cd349d23bd1aa,

title = "Long-term mortality and causes of death in isolated GHD, ISS and SGA patients treated with Recombinant Growth Hormone during childhood in Belgium, The Netherlands and Sweden: Preliminary report of 3 countries participating in the EU SAGhE Studdy",

author = "L Savendahl and M Maes and K Albertsson-Wikland and B Borgstrom and JC Carel and S Henrard and N Speybroeck and M Thomas and G Zandwijken and {Hokken - Koelega}, Anita",

year = "2012",

doi = "10.1210/jc.2011-2882",

language = "Undefined/Unknown",

volume = "97",

pages = "E213--E217",

journal = "Journal of Clinical Endocrinology and Metabolism",

issn = "0021-972X",

publisher = "Endocrine Society",

number = "2",

}

Savendahl, L, Maes, M, Albertsson-Wikland, K, Borgstrom, B, Carel, JC, Henrard, S, Speybroeck, N, Thomas, M, Zandwijken, G & Hokken - Koelega, A 2012, 'Long-term mortality and causes of death in isolated GHD, ISS and SGA patients treated with Recombinant Growth Hormone during childhood in Belgium, The Netherlands and Sweden: Preliminary report of 3 countries participating in the EU SAGhE Studdy', Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 2, pp. E213-E217. https://doi.org/10.1210/jc.2011-2882

Long-term mortality and causes of death in isolated GHD, ISS and SGA patients treated with Recombinant Growth Hormone during childhood in Belgium, The Netherlands and Sweden: Preliminary report of 3 countries participating in the EU SAGhE Studdy. / Savendahl, L; Maes, M; Albertsson-Wikland, K et al.
In: Journal of Clinical Endocrinology and Metabolism, Vol. 97, No. 2, 2012, p. E213-E217.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Long-term mortality and causes of death in isolated GHD, ISS and SGA patients treated with Recombinant Growth Hormone during childhood in Belgium, The Netherlands and Sweden: Preliminary report of 3 countries participating in the EU SAGhE Studdy

AU - Savendahl, L

AU - Maes, M

AU - Albertsson-Wikland, K

AU - Borgstrom, B

AU - Carel, JC

AU - Henrard, S

AU - Speybroeck, N

AU - Thomas, M

AU - Zandwijken, G

AU - Hokken - Koelega, Anita

PY - 2012

Y1 - 2012

U2 - 10.1210/jc.2011-2882

DO - 10.1210/jc.2011-2882

M3 - Article

C2 - 22238393

SN - 0021-972X

VL - 97

SP - E213-E217

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

IS - 2

ER -

Savendahl L, Maes M, Albertsson-Wikland K, Borgstrom B, Carel JC, Henrard S et al. Long-term mortality and causes of death in isolated GHD, ISS and SGA patients treated with Recombinant Growth Hormone during childhood in Belgium, The Netherlands and Sweden: Preliminary report of 3 countries participating in the EU SAGhE Studdy. Journal of Clinical Endocrinology and Metabolism. 2012;97(2):E213-E217. doi: 10.1210/jc.2011-2882